Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation
To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation. Prospective, consecutive study. 12 intensive care units in six towns in Northern Bavaria. A total of 55 apnoea tests were performed on 55 consecutive pati...
Gespeichert in:
Veröffentlicht in: | Intensive care medicine 1997-08, Vol.23 (8), p.903-907 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 907 |
---|---|
container_issue | 8 |
container_start_page | 903 |
container_title | Intensive care medicine |
container_volume | 23 |
creator | LANG, C. J. G |
description | To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation.
Prospective, consecutive study.
12 intensive care units in six towns in Northern Bavaria.
A total of 55 apnoea tests were performed on 55 consecutive patients as part of the determination of brain death, 27 without and 28 with CO2 augmentation.
Apnoea tests following oxygenation with 100% O2 either after reduction of ventilatory volume (A) or after insufflation of CO2 during normoventilation (B). In each case, an arterial partial CO2 pressure of at least 8 kPa was documented.
All apnoea tests were without serious adverse effects (hypoxia, newly induced cardiac arrhythmia, cardiac asystole). An increased dopamine infusion rate was deemed necessary in only one case of group (A) because of marked systolic hypotension (< 8 kPa). Individual variation of systolic and diastolic blood pressure (BP) did not exceed + 62 to -46% and + 49 to -52% respectively, in group (A) and + 35 to -57% and + 40 to -48% respectively, in group (B). Variation of heart rate (HR) remained within the range + 24 to -31% in group (A) and + 37 to -22% in group (B).
HR varied less than BP. The possibility of a marked relative rise of fall of BP in group (A) was equal; in group (B) there was a lower change of rising BP. The chances for a rise or fall in HR were equal for the two groups. There was a tendency for less variation of cardiovascular parameters in group (B). |
doi_str_mv | 10.1007/s001340050430 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79310206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79310206</sourcerecordid><originalsourceid>FETCH-LOGICAL-p263t-1cdec13081244c179aca8f234fe0d4c082be2ee0d25cab7834f773ea129bcad93</originalsourceid><addsrcrecordid>eNpdkM1LAzEQxYMotVaPHoWA4m01k6T7cdTiFxR60ZuwzGaz7ZZtsiZZxP_eVBcPnt4M78fw5hFyDuwGGMtuPWMgJGNzJgU7IFOQgifARX5IpkxInshU8mNy4v02klk6hwmZFAJYDjAl7_edtTXtnfZ-cJqiqelGowvUYdBUbdCstaf14Fqzptgbq5EG7cN-_WzDhlr3o3YIdLHitDV-aJoOQ2vNKTlqsPP6bNQZeXt8eF08J8vV08vibpn0PBUhAVVrBSIG4lIqyApUmDdcyEazWiqW80pzHWc-V1hleTSyTGgEXlQK60LMyPXv3d7ZjyGGK3etV7rr0Gg7-DLbv8tZGsHLf-DWDs7EbCUw4LAvkUXqYqSGaqfrsnftDt1XOZYW_avRR6-waxwa1fo_jGcFh0KIb2NXemA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1012105040</pqid></control><display><type>article</type><title>Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>LANG, C. J. G</creator><creatorcontrib>LANG, C. J. G</creatorcontrib><description>To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation.
Prospective, consecutive study.
12 intensive care units in six towns in Northern Bavaria.
A total of 55 apnoea tests were performed on 55 consecutive patients as part of the determination of brain death, 27 without and 28 with CO2 augmentation.
Apnoea tests following oxygenation with 100% O2 either after reduction of ventilatory volume (A) or after insufflation of CO2 during normoventilation (B). In each case, an arterial partial CO2 pressure of at least 8 kPa was documented.
All apnoea tests were without serious adverse effects (hypoxia, newly induced cardiac arrhythmia, cardiac asystole). An increased dopamine infusion rate was deemed necessary in only one case of group (A) because of marked systolic hypotension (< 8 kPa). Individual variation of systolic and diastolic blood pressure (BP) did not exceed + 62 to -46% and + 49 to -52% respectively, in group (A) and + 35 to -57% and + 40 to -48% respectively, in group (B). Variation of heart rate (HR) remained within the range + 24 to -31% in group (A) and + 37 to -22% in group (B).
HR varied less than BP. The possibility of a marked relative rise of fall of BP in group (A) was equal; in group (B) there was a lower change of rising BP. The chances for a rise or fall in HR were equal for the two groups. There was a tendency for less variation of cardiovascular parameters in group (B).</description><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s001340050430</identifier><identifier>PMID: 9310811</identifier><identifier>CODEN: ICMED9</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Apnea ; Biological and medical sciences ; Blood Gas Analysis ; Blood pressure ; Blood Pressure - drug effects ; Brain death ; Brain Death - diagnosis ; Carbon dioxide ; Carbon Dioxide - pharmacology ; Cardiac arrhythmia ; Clinical death. Palliative care. Organ gift and preservation ; Dopamine ; Female ; Heart rate ; Heart Rate - drug effects ; Humans ; Hypotension ; Hypoxia ; Insufflation ; Intensive care ; Male ; Medical sciences ; Middle Aged ; Monitoring, Physiologic - methods ; Patients ; Prospective Studies ; Statistics, Nonparametric</subject><ispartof>Intensive care medicine, 1997-08, Vol.23 (8), p.903-907</ispartof><rights>1997 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2792193$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9310811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LANG, C. J. G</creatorcontrib><title>Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation</title><title>Intensive care medicine</title><addtitle>Intensive Care Med</addtitle><description>To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation.
Prospective, consecutive study.
12 intensive care units in six towns in Northern Bavaria.
A total of 55 apnoea tests were performed on 55 consecutive patients as part of the determination of brain death, 27 without and 28 with CO2 augmentation.
Apnoea tests following oxygenation with 100% O2 either after reduction of ventilatory volume (A) or after insufflation of CO2 during normoventilation (B). In each case, an arterial partial CO2 pressure of at least 8 kPa was documented.
All apnoea tests were without serious adverse effects (hypoxia, newly induced cardiac arrhythmia, cardiac asystole). An increased dopamine infusion rate was deemed necessary in only one case of group (A) because of marked systolic hypotension (< 8 kPa). Individual variation of systolic and diastolic blood pressure (BP) did not exceed + 62 to -46% and + 49 to -52% respectively, in group (A) and + 35 to -57% and + 40 to -48% respectively, in group (B). Variation of heart rate (HR) remained within the range + 24 to -31% in group (A) and + 37 to -22% in group (B).
HR varied less than BP. The possibility of a marked relative rise of fall of BP in group (A) was equal; in group (B) there was a lower change of rising BP. The chances for a rise or fall in HR were equal for the two groups. There was a tendency for less variation of cardiovascular parameters in group (B).</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Apnea</subject><subject>Biological and medical sciences</subject><subject>Blood Gas Analysis</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Brain death</subject><subject>Brain Death - diagnosis</subject><subject>Carbon dioxide</subject><subject>Carbon Dioxide - pharmacology</subject><subject>Cardiac arrhythmia</subject><subject>Clinical death. Palliative care. Organ gift and preservation</subject><subject>Dopamine</subject><subject>Female</subject><subject>Heart rate</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Hypotension</subject><subject>Hypoxia</subject><subject>Insufflation</subject><subject>Intensive care</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monitoring, Physiologic - methods</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Statistics, Nonparametric</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkM1LAzEQxYMotVaPHoWA4m01k6T7cdTiFxR60ZuwzGaz7ZZtsiZZxP_eVBcPnt4M78fw5hFyDuwGGMtuPWMgJGNzJgU7IFOQgifARX5IpkxInshU8mNy4v02klk6hwmZFAJYDjAl7_edtTXtnfZ-cJqiqelGowvUYdBUbdCstaf14Fqzptgbq5EG7cN-_WzDhlr3o3YIdLHitDV-aJoOQ2vNKTlqsPP6bNQZeXt8eF08J8vV08vibpn0PBUhAVVrBSIG4lIqyApUmDdcyEazWiqW80pzHWc-V1hleTSyTGgEXlQK60LMyPXv3d7ZjyGGK3etV7rr0Gg7-DLbv8tZGsHLf-DWDs7EbCUw4LAvkUXqYqSGaqfrsnftDt1XOZYW_avRR6-waxwa1fo_jGcFh0KIb2NXemA</recordid><startdate>19970801</startdate><enddate>19970801</enddate><creator>LANG, C. J. G</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>19970801</creationdate><title>Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation</title><author>LANG, C. J. G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p263t-1cdec13081244c179aca8f234fe0d4c082be2ee0d25cab7834f773ea129bcad93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Apnea</topic><topic>Biological and medical sciences</topic><topic>Blood Gas Analysis</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Brain death</topic><topic>Brain Death - diagnosis</topic><topic>Carbon dioxide</topic><topic>Carbon Dioxide - pharmacology</topic><topic>Cardiac arrhythmia</topic><topic>Clinical death. Palliative care. Organ gift and preservation</topic><topic>Dopamine</topic><topic>Female</topic><topic>Heart rate</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Hypotension</topic><topic>Hypoxia</topic><topic>Insufflation</topic><topic>Intensive care</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monitoring, Physiologic - methods</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Statistics, Nonparametric</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LANG, C. J. G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LANG, C. J. G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation</atitle><jtitle>Intensive care medicine</jtitle><addtitle>Intensive Care Med</addtitle><date>1997-08-01</date><risdate>1997</risdate><volume>23</volume><issue>8</issue><spage>903</spage><epage>907</epage><pages>903-907</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><coden>ICMED9</coden><abstract>To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation.
Prospective, consecutive study.
12 intensive care units in six towns in Northern Bavaria.
A total of 55 apnoea tests were performed on 55 consecutive patients as part of the determination of brain death, 27 without and 28 with CO2 augmentation.
Apnoea tests following oxygenation with 100% O2 either after reduction of ventilatory volume (A) or after insufflation of CO2 during normoventilation (B). In each case, an arterial partial CO2 pressure of at least 8 kPa was documented.
All apnoea tests were without serious adverse effects (hypoxia, newly induced cardiac arrhythmia, cardiac asystole). An increased dopamine infusion rate was deemed necessary in only one case of group (A) because of marked systolic hypotension (< 8 kPa). Individual variation of systolic and diastolic blood pressure (BP) did not exceed + 62 to -46% and + 49 to -52% respectively, in group (A) and + 35 to -57% and + 40 to -48% respectively, in group (B). Variation of heart rate (HR) remained within the range + 24 to -31% in group (A) and + 37 to -22% in group (B).
HR varied less than BP. The possibility of a marked relative rise of fall of BP in group (A) was equal; in group (B) there was a lower change of rising BP. The chances for a rise or fall in HR were equal for the two groups. There was a tendency for less variation of cardiovascular parameters in group (B).</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>9310811</pmid><doi>10.1007/s001340050430</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0342-4642 |
ispartof | Intensive care medicine, 1997-08, Vol.23 (8), p.903-907 |
issn | 0342-4642 1432-1238 |
language | eng |
recordid | cdi_proquest_miscellaneous_79310206 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Apnea Biological and medical sciences Blood Gas Analysis Blood pressure Blood Pressure - drug effects Brain death Brain Death - diagnosis Carbon dioxide Carbon Dioxide - pharmacology Cardiac arrhythmia Clinical death. Palliative care. Organ gift and preservation Dopamine Female Heart rate Heart Rate - drug effects Humans Hypotension Hypoxia Insufflation Intensive care Male Medical sciences Middle Aged Monitoring, Physiologic - methods Patients Prospective Studies Statistics, Nonparametric |
title | Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A18%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blood%20pressure%20and%20heart%20rate%20changes%20during%20apnoea%20testing%20with%20or%20without%20CO2%20insufflation&rft.jtitle=Intensive%20care%20medicine&rft.au=LANG,%20C.%20J.%20G&rft.date=1997-08-01&rft.volume=23&rft.issue=8&rft.spage=903&rft.epage=907&rft.pages=903-907&rft.issn=0342-4642&rft.eissn=1432-1238&rft.coden=ICMED9&rft_id=info:doi/10.1007/s001340050430&rft_dat=%3Cproquest_pubme%3E79310206%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1012105040&rft_id=info:pmid/9310811&rfr_iscdi=true |